
Preparing for an IPO: Financial and Valuation Risks for Life Science Companies and How to Address Them
In a recent BPM webinar, partners Sarah Weaver, Justin J. Kay, and Kemp Moyer shared what they see slow companies down and what sets apart the ones who are ready when the window opens.
